Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May

Illumina to Webcast Live Presentation at Upcoming Investment Conferences in May

SAN DIEGO--(BUSINESS WIRE)-- Illumina, Inc. (Nasdaq: ILMN  ) today announced that it will webcast the Company’s presentation at three upcoming investment conferences.

Illumina will webcast its presentation at the Robert W. Baird Growth Stock Conference in Chicago, Illinois, on May 8, 2013. The live webcast is scheduled to begin at 2:10 PM CT and will feature a brief overview of the company by Christian Henry, Senior Vice President and General Manager, Genomic Solutions, followed by a question and answer session.

Illumina will also webcast its presentation at the Bank of America Merrill Lynch Health Care Conference in Las Vegas, Nevada, on May 14, 2013. The live webcast is scheduled to begin at 4:20 PM PT and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session.

Illumina will also webcast its presentation at the UBS Global Healthcare Conference in New York, New York, on May 20, 2013. The live webcast is scheduled to begin at 11:30 AM ET and will feature a brief overview of the company by Marc Stapley, Senior Vice President and Chief Financial Officer, followed by a question and answer session.

The webcast can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com.

About Illumina

Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.



Illumina, Inc.
Investors:
Rebecca Chambers, 858-255-5243
rchambers@illumina.com
or
Media:
Jennifer Temple, 858-882-6822
pr@illumina.com

KEYWORDS:   United States  North America  California  Illinois  Nevada  New York

INDUSTRY KEYWORDS:

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2399477, ~/Articles/ArticleHandler.aspx, 11/28/2014 12:03:19 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...